Clinical Trial Update: Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing N-Acetylcysteine as therapy for chronic fatigue syndrome/myalgic encephalomyelitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 2 | Status: RECRUITING